LPAR5 is upregulated in papillary thyroid carcinoma (PTC), and downregulation of LPAR5 decreases the proliferation and migration phenotype via the PI3K/Akt pathway [34]. Here, LPAR5 is linked to thyroid gland papillary carcinoma.